A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

NCT01763580 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

MCNS
Minimal Change Nephrotic Syndrome (MCNS)

Interventions

DRUG: Tacrolimus
DRUG: Prednisolone

Sponsor

Astellas Pharma Korea, Inc.